$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Oct 14, 2025)
$53.44M
Market Cap
-
P/E Ratio
-1.1
EPS
$2.52
52 Week High
$0.24
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
BioAtla, Inc. is an innovative biopharmaceutical company based in San Diego, California, focused on the development of advanced antibody-based therapies targeting various forms of cancer. Utilizing its proprietary Bispecific T cell Engager (BiTEx™) platform, BioAtla is pioneering treatments that are designed to selectively eliminate cancer cells while minimizing damage to healthy tissue. The company aims to address significant unmet medical needs in oncology with a robust pipeline of product candidates, positioning itself as a leader in the evolving cancer therapeutics landscape.